Statement Of Financial Position [Abstract]

Transgene - Filing #2816866

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	11 295 EUR	—	—	—	—	—	—	—	13 110 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	5 911 EUR	—	—	—	—	—	—	—	5 277 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1 343 EUR	—	—	—	—
Assets	—	—	101 838 EUR	—	—	—	—	—	—	—	85 453 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	48 886 EUR	—	—	—	—	—	—	—	41 921 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity	31 092 EUR	2 933 EUR	67 209 EUR	1 423 EUR	19 536 EUR	67 209 EUR	67 441 EUR	48 886 EUR	50 716 EUR	39 212 EUR	50 716 EUR	1 051 EUR	13 861 EUR	1 726 EUR	41 921 EUR	17 231 EUR	2 026 EUR	36 978 EUR	37 712 EUR	1 058 EUR	83 265 EUR	66 163 EUR	18 804 EUR	65 697 EUR	2 026 EUR	37 712 EUR	—	37 444 EUR	1 058 EUR	83 265 EUR	18 804 EUR
Liabilities [abstract]
Provisions [abstract]
Provisions for employee benefits	—	—	3 958 EUR	—	—	—	—	—	—	—	4 060 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Liabilities	—	—	34 629 EUR	—	—	—	—	—	—	—	34 737 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	—	—	101 838 EUR	—	—	—	—	—	—	—	85 453 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—